Clinical-Grade Biohacking.

Dual GLP-1 / GIP agonist. Insulin sensitivity optimisation and body recomposition.

Triple GLP-1 / GIP / Glucagon agonist. Body recomposition and advanced metabolic management.

GLP-1 agonist. Glycaemic control and sustained weight reduction.

Long-acting amylin analogue. Appetite modulation and gastric emptying.

Cagrilintide and semaglutide combination. Studied in appetite modulation and metabolic control.

Selective GH secretagogue via the ghrelin receptor, without relevant cortisol effect.

Stabilised GHRH analogue. Studied in visceral fat and body composition.

GHRH fragment 1-29. Studied in pulsatile growth hormone release.

GH secretagogue via the ghrelin receptor. Studied in GH and IGF-1 release.

GH secretagogue via the ghrelin receptor. Studied in appetite and GH release.

GHRP-family GH secretagogue. Studied in GH release and cardiac signalling.

Short-acting GHRH analogue. Studied in growth hormone pulsatility.

GHRH analogue with Drug Affinity Complex. Extended half-life versus the non-DAC form.

191-amino-acid somatropin. Studied in body composition and tissue recovery.

Long-half-life IGF-1 analogue. Studied in hypertrophy and anabolic signalling.

Mechano growth factor, an IGF-1 splice variant. Studied in muscle repair.

PEGylated MGF. Extended half-life versus native MGF.

Myostatin antagonist. Studied in hypertrophy and skeletal muscle regulation.

hGH fragment 176-191. Studied in lipolysis without IGF-1 effects.

CJC-1295 with ipamorelin formulation. Combines a GHRH analogue and a ghrelin secretagogue.

Tesamorelin with ipamorelin formulation, across the GHRH axis and the ghrelin receptor.

Tesamorelin, ipamorelin and CJC-1295 formulation across the growth hormone axis.

Four-component formulation across the GH axis, mitochondrial signalling and lipolysis.

Gastric juice-derived pentadecapeptide. Studied in tissue repair and angiogenesis.

Synthetic thymosin β4 fragment. Studied in tissue repair and cell migration.

Copper tripeptide. Studied in collagen synthesis and extracellular matrix remodelling.

C-terminal α-MSH tripeptide. Studied in inflammatory response modulation.

Cathelicidin-family antimicrobial peptide. Studied in innate immunity.

28-amino-acid thymic peptide. Studied in immune response modulation.

Erythropoietin-derived peptide without haematopoietic effect. Studied in neuropathy.

BPC-157, GHK-Cu, KPV and TB-500 formulation oriented to tissue repair.

BPC-157 with TB-500 formulation, the two most studied peptides in tissue repair.

Two-thymic-peptide formulation. Studied in immune response modulation.

Two thymic peptides with KPV, across immunity and inflammatory response.

Nicotinamide adenine dinucleotide. Central cofactor in mitochondrial energy metabolism.

NAD+ produced by biofermentation. Cofactor in mitochondrial energy metabolism.

Chemically synthesised NAD+. Cofactor in mitochondrial energy metabolism.

Mitochondrial genome-encoded peptide. Studied in metabolic homeostasis.

40 mg mitochondrial peptide presentation. Studied in metabolic homeostasis.

Mitochondria-derived peptide. Studied in cytoprotection and metabolic signalling.

Synthetic tetrapeptide derived from the pineal gland. Studied in telomerase and circadian rhythm.

Peptide targeting cardiolipin in the inner mitochondrial membrane. Studied in bioenergetics.

D-retro-inverso peptide targeting the FOXO4-p53 interaction. Studied in senolysis.

NNMT inhibitor. Researched in adipose tissue metabolism and cellular NAD+.

Pan-ERR agonist. Studied as an exercise mimetic and in oxidative capacity.

ACTH(4-10)-derived heptapeptide. Studied in BDNF and cognitive function.

Tuftsin-analogue heptapeptide. Studied in anxiety and neurotransmitter balance.

Delta sleep-inducing peptide. Studied in sleep architecture and stress response.

Short pineal peptide bioregulator. Studied in cognitive function.

Preparation of neurotrophic peptide fragments. Studied in neuroprotection.

DSIP with selank formulation, across sleep and stress response.

Formulation of the two most studied peptide nootropics of the Russian family.

Melanocortin receptor agonist. Studied in the central pathway of sexual desire.

Three-component formulation across melanocortin pathways and the reproductive axis.

GnRH-regulating neuropeptide. Studied in the reproductive axis.

GnRH analogue. Studied in the hypothalamic-pituitary-gonadal axis.

Vasoactive intestinal peptide. Studied in vasodilation and immune modulation.

Hypothalamic nonapeptide. Studied in social behaviour and uterine signalling.

BPC-157, GHK-Cu and TB-500 formulation. Studied in skin quality and cutaneous repair.

SNAP-25-derived octapeptide. Studied in dermatological research on expression lines.